Schedule 13G ownership disclosure

Krystal Biotech Inc

COMMON STOCK · CUSIP: 501147102

Event date: 2024-12-31

Filing-level shares
1,278,975.00
Percent of class
4.4%
  • STATE STREET CORPORATION

    Shares: 1,278,975.00 · Class: 4.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-25-000090
Form type
SCHEDULE 13G
Filer
Krystal Biotech, Inc.
CIK
CIK 1711279
Filed
Feb 05, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub